Systolic and diastolic blood pressure

Biomarker

2 papers2 findings

  • Human trial1
  • Humans1

Interventions

1

Faith-based health education

downin humans1

1 study
  1. Faith-based health education decreases systolic and diastolic blood pressure in humans.

    “Results demonstrated that both systolic and diastolic BP measurements were reduced.”

    Human trialAfrican American participants with self-reported hypertension; one-group pretest-posttest study6 weekly 60-minute educational sessions6 weeksn = 21

    An Evidence-Based Approach to Nonpharmacological Blood Pressure Management Among African Americans

    Journal of doctoral nursing practice15 Oct 2026

More on Faith-based health education

Associations

1

Tirzepatide or semaglutide use

downin humans1

1 study
  1. Tirzepatide or semaglutide use is associated with systolic and diastolic blood pressure in humans.

    “Significant improvements were observed in A1c, BMI, systolic and diastolic BP, LDL, and triglycerides (p < .001).”

    HumansRural-dwelling adults with prediabetes and overweight or obesity3–24 monthsn = 40

    A Retrospective Chart Review of Tirzepatide and Semaglutide Use in Prediabetes Management and Cardiometabolic Outcomes in a Rural Primary Care Setting

    Journal of doctoral nursing practice15 Oct 2026

More on Tirzepatide or semaglutide use

Latest

Nov 2025: 9Dec 2025: 8Jan 2026: 2Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 2Jun 2026: 1Jul 2026: 4Aug 2026: 17Sep 2026: 10Oct 2026: 1064 in 12 months